ABSTRACT NUMBER: ESOC2026A1033 STICKY PLATELET SYNDROME CAN CAUSE RECURRING TRANSIENT ISCHEMIC ATTACK: A CASE REPORT

Abstract Background and aims While ischemic stroke (IS) caused by sticky platelet syndrome syndrome (SPS) is rare, SPS was actually first described in a group of young-aged IS patients.1 We report a case of IS and recurring transient ischemic attack (TIA) caused by SPS to raise awareness of the effect of SPS to the cerebrovascular system. Methods A 57-year-old male came with slurred speech and right sided weakness. He had no history of hypertension and diabetes mellitus; was diagnosed with coronary artery disease a month before and currently taking antiplatelet and statin. The brain MRI showed hyperacute-acute infarction in left corona-radiata and basal-ganglia. The deficits lasted no more than 24 hours. MR, CT, and digital subtraction angiography were done with no remarkable result. The D-dimer, fibrinogen, protein C and S level were within normal limits. The peripheral blood smear demonstrated massive platelet clumping (Figure 1), while platelet antibody test was negative. The patient was discharged with additional acetyl-salicylic-acid (ASA) 80 mg. He then underwent less-than-24-hour right-sided weakness nine times, before benefiting from cilostazol 100 mg bid. The platelet clumping resolved, and the platelet aggregation test demonstrates hypoaggregation. Results Since there is no other significant risk factor, the unusual clumping condition of platelets suggests SPS as the cause of the recurrence TIA. Although low-dose ASA is reported to be effective to reverse hyperaggregability,2 the patient took better benefit from cilostazol. Conclusions While the diagnostic procedure of it is yet to be standardized, SPS should be considered as a risk factor for cryptogenic IS. Conflict of interest Anthonius Kurniadi: nothing to disclose. Linny Luciana: nothing to disclose. Figure 1 - belongs to Methods

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1476
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1033 STICKY PLATELET SYNDROME CAN CAUSE RECURRING TRANSIENT ISCHEMIC ATTACK: A CASE REPORT

Linny Luciana, Anthonius Kurniadi
European Stroke Journal
Platelet Disorders and Treatments
article

ABSTRACT NUMBER: ESOC2026A1033 STICKY PLATELET SYNDROME CAN CAUSE RECURRING TRANSIENT ISCHEMIC ATTACK: A CASE REPORT

Linny Luciana, Anthonius Kurniadi
article en

Abstract

Abstract Background and aims While ischemic stroke (IS) caused by sticky platelet syndrome syndrome (SPS) is rare, SPS was actually first described in a group of young-aged IS patients.1 We report a case of IS and recurring transient ischemic attack (TIA) caused by SPS to raise awareness of the effect of SPS to the cerebrovascular system. Methods A 57-year-old male came with slurred speech and right sided weakness. He had no history of hypertension and diabetes mellitus; was diagnosed with coronary artery disease a month before and currently taking antiplatelet and statin. The brain MRI showed hyperacute-acute infarction in left corona-radiata and basal-ganglia. The deficits lasted no more than 24 hours. MR, CT, and digital subtraction angiography were done with no remarkable result. The D-dimer, fibrinogen, protein C and S level were within normal limits. The peripheral blood smear demonstrated massive platelet clumping (Figure 1), while platelet antibody test was negative. The patient was discharged with additional acetyl-salicylic-acid (ASA) 80 mg. He then underwent less-than-24-hour right-sided weakness nine times, before benefiting from cilostazol 100 mg bid. The platelet clumping resolved, and the platelet aggregation test demonstrates hypoaggregation. Results Since there is no other significant risk factor, the unusual clumping condition of platelets suggests SPS as the cause of the recurrence TIA. Although low-dose ASA is reported to be effective to reverse hyperaggregability,2 the patient took better benefit from cilostazol. Conclusions While the diagnostic procedure of it is yet to be standardized, SPS should be considered as a risk factor for cryptogenic IS. Conflict of interest Anthonius Kurniadi: nothing to disclose. Linny Luciana: nothing to disclose. Figure 1 - belongs to Methods

European Stroke JournalVol. 11(Supplement_1)
Universitas Islam 45 Bekasi (ID)
Good health and well-being
Openalex Percentile: Top 8%
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.